Emergency room visits involving popular sleep drug rise sharply

Published: August, 2013

Emergency room visits related to the commonly prescribed sleep drug zolpidem (Ambien, Edluar, Zolpimist) have increased sharply, according to the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA). The number of ER visits by men related to adverse reactions to zolpidem rose 144%, from 2,584 in 2005 to 6,306 in 2010.

Zolpidem is prescribed for short-term relief of sleeplessness. The drug can have lingering effects the next day, increasing the risk of accidents. The FDA recently moved to require zolpidem manufacturers to cut the recommended dose for women in half. The agency recommended the same change for men, though it is not legally required.

To continue reading this article, you must log in.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »